Literature DB >> 12217242

Antiphospholipid antibodies in pediatrics.

Ana I Quintero-Del-Rio1.   

Abstract

Antiphospholipid antibody syndrome has been associated with vascular thrombosis, thrombocytopenia, hemolytic anemia, livedo reticularis, neurologic disorders, and recurrent fetal loss. The diagnosis of antiphospholipid syndrome is given in the presence of an elevated anticardiolipin antibody lupus anticoagulant in addition to a thrombotic event. Antiphospholipid antibodies are responsible for a majority of thrombotic events in children. These antibodies can present as a primary syndrome or secondary to other diseases, such as systemic lupus erythematosus. Anticoagulation therapy with heparin and low-dose aspirin is the recommended treatment in pediatric patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217242     DOI: 10.1007/s11926-002-0082-1

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  49 in total

1.  Correction for age of anticardiolipin antibodies cut-off points.

Authors:  E Rapizzi; A Ruffatti; M Tonello; A Piccoli; A Calligaro; P Sfriso; S Todesco
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Anti-cardiolipin antibodies in fetal blood and amniotic fluid derived from patients with the anti-phospholipid syndrome.

Authors:  S B Cohen; M Goldenberg; J Rabinovici; A L Lidor; M Dulitzky; B Gilburd; Y Shoenfeld; E Schiff
Journal:  Hum Reprod       Date:  2000-05       Impact factor: 6.918

Review 3.  Management of antiphospholipid syndrome during pregnancy.

Authors:  M S Esplin
Journal:  Clin Obstet Gynecol       Date:  2001-03       Impact factor: 2.190

4.  Sudden onset profound deafness in association with antiphospholipid antibodies in a child with SLE.

Authors:  K S Agarwal; J M Puliyel; U Khanduri
Journal:  Indian Pediatr       Date:  2000-11       Impact factor: 1.411

Review 5.  Antiphospholipid syndrome and recurrent miscarriages.

Authors:  D Vinatier; P Dufour; M Cosson; J L Houpeau
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2001-05       Impact factor: 2.435

6.  Primary antiphospholipid antibody syndrome and mesangial IgA glomerulonephritis.

Authors:  R Sinniah; H C Gan; K H Yoon
Journal:  Am J Nephrol       Date:  2001 Mar-Apr       Impact factor: 3.754

7.  Effects of inherited thrombophilic mutations in an adolescent with antiphospholipid syndrome and systemic lupus erythematosus.

Authors:  E A Higginbotham; S A Zimmerman; T A Howard; L Schanberg; D Kredich; R E Ware
Journal:  J Rheumatol       Date:  2001-02       Impact factor: 4.666

Review 8.  Transient visual symptoms in systemic lupus erythematosus and antiphospholipid syndrome.

Authors:  D Giorgi; V David; A Afeltra; C B Gabrieli
Journal:  Ocul Immunol Inflamm       Date:  2001-03       Impact factor: 3.070

9.  Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone.

Authors:  K E Moss; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2001-08       Impact factor: 7.580

Review 10.  Management of thrombosis in antiphospholipid antibody syndrome.

Authors:  M Petri
Journal:  Rheum Dis Clin North Am       Date:  2001-08       Impact factor: 2.670

View more
  2 in total

1.  Anticardiolipin antibodies in dogs.

Authors:  R Papini; O Pellegrini; C Rossini; G Guidi
Journal:  Vet Res Commun       Date:  2004-08       Impact factor: 2.459

2.  Presence of lupus anticoagulant in an asymptomatic Nigerian.

Authors:  Edeghonghon E Olayemi; Godwin N Bazuaye
Journal:  Afr Health Sci       Date:  2007-09       Impact factor: 0.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.